Expert Pitch

Contact tracing a ‘tried-and-true tool’ for public health

Cornell University
11-May-2020 2:30 PM EDT, by Cornell University

As the nation looks to re-open, contact tracers will be needed to track and halt the spread of COVID-19.

Gen Meredith, an expert in public health assessment, intervention development and workforce capacity building explains contact tracing and its importance. Meredith can also speak to what will need to be done to recruit, train, and deploy contact tracers in New York.

Bio: https://www.vet.cornell.edu/research-departments/faculty/gen-meredith-otr-mph

Meredith says:

“Contact tracing is a tried-and-true tool from the public health toolkit. Contact tracing has been around for decades and it is so powerful because it allows public health leaders to do three key things: (1) get people who may have been exposed connected with the testing, treatment and care services; (2) provide people who are infected – or potentially infected, pending test results – with the knowledge and tools they need to reduce risk, increase health, and keep others safe; and (3) gather more specific information about what is driving or spreading an infection.

“In practical terms, for COVID-19, every person who is getting tested is considered ‘infected’ until the test comes back negative. So, ideally, for every person tested, contact tracing starts. This is why there is an urgent need to recruit, train, and deploy contact tracers.

“Contact tracers, also known as disease detectives, contact people who are infected with or have been exposed to a pathogen that can be transmitted to others. Contact tracers speak with the individual to help them understand what they might expect if they are positive ­– such as who to call if they have symptoms, or where to get treatment; help the individual know how to keep their friends and family safe and how to not spread the infection; and, help the individual recall activities or interactions that have occurred that could have resulted in their own infection, or transmission of the infection to others. The contact tracers try to gather names of people who might be at risk, or locations where transmission could have happened and then contact the people who may have been exposed ­– never naming the person who is infected – and the process starts all over again.

“Public health leaders want to make sure that everyone who may have been exposed to COVID-19 knows where to get tested and gets tested. They also want people to know how the virus is spreading in communities and who is most at risk for more severe illness. This data informs how and when we re-open, and how to keep more people safe; contact tracers make that happen.”

Please find other experts at Cornell available to discuss the coronavirus crisis from science  and public health perspectivefor its impact on the economy, its effects on countries around the world and in the ways the pandemic is changing our daily lives.

-30-




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
2.84685